Company Filing History:
1 out of 30 
1 out of 832,880 Years Active: 2002-2003
Title: Innovator Andreas Hahn: Pioneering Cardiac Device Technologies
Introduction: Andreas Hahn, an accomplished inventor based in Berlin, Germany, has made significant contributions to the field of cardiology through his innovative patents. With two patents to his name, he has developed methods that enhance the functionality and reliability of cardiac devices.
Latest Patents: Andreas Hahn's latest patents focus on advancing cardiologic devices. One notable patent is the "Method of Detecting Cardiac Interval Signals in Cardiologic Devices." This innovative approach addresses the challenge of avoiding far-field QRS in tachy detection devices. The method involves a detailed strategy for heart pacemakers and implantable cardioverter-defibrillators (ICDs). It generates a Short Atrial Refractory Period (SARP) following an atrial event, carefully blanks the atrial detector after a ventricular event, and employs a Post Ventricular Short Atrial Refractory Period (PVSARP) to improve signal detection. Moreover, it modulates the sensitivity of amplifiers for atrial signals to optimize performance and response times.
Career Highlights: Throughout his career, Andreas Hahn has collaborated with various esteemed organizations, including Biotronik Mess- und Therapiegeräte GmbH & Co. Ingenieurbüro Berlin, where he contributed to critical advancements in medical technology. His expertise and innovative ideas have significantly influenced the development of cardiac devices, ensuring that they perform at optimal levels.
Collaborations: During his professional journey, Andreas has worked alongside notable colleagues, including Andreas Kucher and Indra B. Nigam. These collaborations have fostered a dynamic exchange of ideas and knowledge, enhancing the inventive processes and outcomes in the field of cardiology.
Conclusion: Andreas Hahn stands out as a notable inventor in the medical technology sector, particularly in cardiology. His innovative patents demonstrate a strong commitment to improving cardiac device functionality and patient outcomes. With his expertise and collaborative spirit, he continues to pave the way for future innovations in the field.